Evidence map›Paper›PMID 15016855›Full record

ArticleJournal of virology2004

Qualitative T-helper responses to multiple viral antigens correlate with vaccine-induced immunity to simian/human immunodeficiency virus infection.

Petra Mooij, Ivonne G Nieuwenhuis, Christiaan J Knoop, Robert W Doms, Willy M J M Bogers, Peter J F Ten Haaft, Henk Niphuis, Wim Koornstra, Kurt Bieler, Josef Köstler and 5 more

Abstract read
In one paragraph

Article in Journal of virology, 2004. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Multiparameter flow cytometry monitoring of T cell responses.Methods in molecular biology (Clifton, N.J.) · 2009
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Petra MooijDepartment of Virology, Biomedical Primate Research Center, 2280 GH Rijswijk, The Netherlands. mooij@bprc.nl
Ivonne G Nieuwenhuis
Christiaan J Knoop
Robert W Doms
Willy M J M Bogers
Peter J F Ten Haaft
Henk Niphuis
Wim Koornstra
Kurt Bieler
Josef Köstler
Brør Morein
Aurelio Cafaro
Barbara Ensoli
Ralf Wagner
Jonathan L Heeney

Funding

Prime-Boost Strategies using IscomsP01AI048225 · NIAID · NOVARTIS VACCINES AND DIAGNOSTICS, INC. · PI BARNETT, SUSAN W · 2002 to 2004
$6.6M
NIAID NIH HHS 1P01 AI48225-01A2NIAID NIH HHS P01 AI048225
6 · The paper itself

Abstract

Evidence is accumulating that CD4(+) T-helper (Th) responses play a critical role in facilitating effector responses which are capable of controlling and even preventing human immunodeficiency virus (HIV) infection. The present work was undertaken to determine whether immunization with multiple antigens influenced individual Th responses and increased protection relative to a single antigen. Rhesus macaques were primed with DNA and boosted (immune-stimulating complex-formulated protein) with a combination of regulatory and structural antigens (Tat-Env-Gag) or with Tat alone. Immunization with combined antigens reduced the magnitude of the responses to Tat compared to the single-antigen immunization. Interestingly, the Th immune responses to the individual antigens were noticeably different. To determine whether the qualitative differences in vaccine-induced Th responses correlated with vaccine efficacy, animals were challenged intravenously with simian/human immunodeficiency virus (strain SHIV(89.6p)) 2 months following the final immunization. Animals that developed combined Th1- and Th2-like responses to Gag and Th2 dominant Env-specific responses were protected from disease progression. Interestingly, one animal that was completely protected from infection had the strongest IFN-gamma and interleukin-2 (IL-2) responses prior to challenge, in addition to very strong IL-4 responses to Gag and Env. In contrast, animals with only a marked vaccine-induced Tat-specific Th2 response (no IFN-gamma) were not protected from infection or disease. These data support the rationale that effective HIV vaccine-induced immunity requires a combination of potent Th1- and Th2-like responses best directed to multiple antigens.

Indexed as

AIDS VaccinesAnimalsCD4-Positive T-LymphocytesHIV-1HIV AntibodiesHIV AntigensHIV InfectionsMacaca mulattaRNA, ViralSAIDS VaccinesSimian Acquired Immunodeficiency SyndromeSimian Immunodeficiency VirusTh1 CellsTh2 CellsT-Lymphocytes, CytotoxicViral LoadAIDS VaccinesHIV AntibodiesHIV AntigensRNA, ViralSAIDS Vaccines

Identifiers

PMID15016855
PMCPMC371051

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.